LRG Virtual Tumor Board Benefits Multiple Patients Globally
The first LRG Virtual Tumor Review Board for 2022 was held in April. There were four cases presented from all over the world, emphasizing the importance of virtual reviews.
The first LRG Virtual Tumor Review Board for 2022 was held in April. There were four cases presented from all over the world, emphasizing the importance of virtual reviews.
ASCO’s Annual Meeting will feature GIST in 18 abstracts, posters, panels, and presentations. Here is a preview of the topics that will be presented at the conference in June.
In March, Director of Data Mgmt and Research, Sahibjeet Kaur joined the GIST experts of AIIMS for the 99th Virtual Patient Support Group addressing patients from India.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Paul Nadolny shares his story.
Australian GIST Advocates Overcome Payer Obstacles Concerning Qinlock. 4th line drug approval was approved! GISTer Sarah McGoram shares the news.
Each member has a unique story, but all reflect the intrinsic courage of one facing the challenge of GIST. Martha Hunt shares her story.
Publicado por Colectivo GIST España - Concluimos el mes dedicado a la concienciación del sarcoma & GIST publicando una actualización del tratamiento para los tumores GIST avanzados.
The newest GISTer to join the ranks of LRG Global Representatives is Nandini Dabbir of Hyderabad, India. She is a the Friends of Max City Chapter Leader & GIST Advocate working with the LRG to support GIST patients on their journey.
It's time to shorten the time to effective treatment access. Fundación GIST Chile shares their story.
The average GIST patient is in their 50s or older when diagnosed with GIST. The rare exception is usually a pediatric SDH- deficient GIST, but April’s case is a case of ‘the rarest of the rare’ in that she was only 20 years old when she first encountered GIST and was not SDH-deficient.
If you didn't find what you were looking for, try a new search!